Yahoo Web Search

  1. Biotech Stock On The Radar: Veru, A Catalyst-Rich Biopharma

    Benzinga via Yahoo FinanceJul 31 17:50 PM

    Thinly traded micro-cap Veru Inc (NASDAQ: VERU) has added about 62% year to date — a commendable performance compared to the broader biotech sector. After peaking at just under ...

  2. Geron (GERN) Stock Up Despite Q2 Earnings & Sales Miss

    Zacks via Yahoo FinanceAug 02 14:48 PM

    This includes one-time cost of $20-$25 million related to activities for transition of imetelstat from Janssen to Geron and purchase of material for the phase III portion of IMerge study ...

  3. Halozyme Therapeutics Inc (HALO) Q2 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 08 14:58 PM

    I would now like to turn the conference over to Al Kildani, Vice President of Investor Relations and Corporate Communications for Halozyme Therapeutics. Good afternoon, everyone and thank you for joining us today.

  4. Edited Transcript of TBPH earnings conference call or presentation 31-Jul-19 12:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceAug 02 21:44 PM

    Winningham, Theravance Biopharma, Inc. - Chairman & CEO [3] -------------------------------------------------------------------------------- Thanks, Jessica...create transformational ...

  5. Edited Transcript of HALO earnings conference call or presentation 6-Aug-19 8:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceAug 15 21:06 PM

    Our partners continue to...royalty revenues from our ENHANZE business. We have licensed our rHuPH20 enzyme to 9 leading pharmaceutical and biotech companies, covering over 50 potential ...

  6. Edited Transcript of GEN.CO earnings conference call or presentation 14-Aug-19 4:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceAug 16 7:28 AM

    We believe that it will increase Genmab's feasibility as a world-class innovation powerhouse within the biotech industry and among key thought leaders in academia and in the financial ...

  7. Edited Transcript of NKTR earnings conference call or presentation 8-Aug-19 9:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceAug 15 9:22 AM

    We recently entered into an agreement with Janssen in which they will study NKTR-255 in preclinical models combined with therapies in their oncology portfolio. And we will contribute ...

  1. Ads
    related to Janssen Biotech, Inc